Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Operating Expenses | 4,185 | 5,814 | 10,561 | 658 | 496 |
| Operating Income | -4,185 | -5,814 | -10,561 | -658 | -496 |
| Interest Expense | 120 | 32 | 0 | 0 | 0 |
| Other Income | -4,047 | 27 | -399 | 94 | -246 |
| Pre-tax Income | -8,352 | -5,819 | -10,960 | -564 | -742 |
| Net Income Continuous | -8,352 | -5,819 | -10,960 | -564 | -742 |
| Net Income | $-8,352 | $-5,819 | $-10,960 | $-564 | $-742 |
| EPS Basic Total Ops | -11.00 | -7.00 | -15.00 | -1.00 | -1.00 |
| EPS Basic Continuous Ops | -10.82 | -7.44 | -14.80 | -0.78 | -1.20 |
| EPS Diluted Total Ops | -11.00 | -7.00 | -15.00 | -1.00 | -1.00 |
| EPS Diluted Continuous Ops | -10.82 | -7.44 | -14.80 | -0.78 | -1.20 |
| EBITDA(a) | $-1,836 | $-3,197 | $-10,543 | $-640 | $-440 |